Category: by country

Authors withdraw study, citing “accidentally duplicated” images

Researchers in Australia have withdrawn a 2006 paper in The Journal of Biological Chemistry (JBC), citing image duplication.

In the withdrawal notice, published July 14, 2017, the authors claim that the “errors do not impact the underlying scientific findings of the article.”

Although the notice does not mention an investigation, a comment on PubPeer on March 2017—signed by Mark Hargreaves, the vice-chancellor at the University of Melbourne—indicates that the university conducted an investigation to assess the issues in the paper and determined that research misconduct “did not occur.”

Here’s the withdrawal notice for “Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1:” Continue reading Authors withdraw study, citing “accidentally duplicated” images

Carlo Croce, Ohio State researcher facing misconduct allegations, suing New York Times for defamation

Carlo Croce

Carlo Croce, a cancer researcher at The Ohio State University who has faced numerous allegations of research misconduct, has filed a lawsuit against the New York Times, claiming the newspaper defamed him in a March 8 story.

Croce filed the civil suit May 10, in the US District Court for the Southern District of Ohio, naming as co-defendants Times reporters James Glanz and Agustin Armendariz, publisher Arthur Sulzberger, Jr., and executive editor Dean Baquet. According to court documents, he’s seeking damages in excess of $75,000. The Times lawsuit was first reported by Courthouse News in May, but it’s actually the second defamation suit Croce filed that we know of.

In April, we’ve recently learned, Croce filed a separate defamation lawsuit against David Sanders, a professor at Purdue University and a key source for the Times story. Croce is seeking damages from Sanders in excess of $75,000.

Croce’s lawyer, Thomas Hill, of Columbus, Ohio firm Kegler Brown Hill + Ritter, told Retraction Watch his client was fighting a “David and Goliath battle” against the Times: Continue reading Carlo Croce, Ohio State researcher facing misconduct allegations, suing New York Times for defamation

Author who previously claimed plagiarism was a mistake earns new erratum

A biotechnology journal has corrected a 2006 paper after discovering duplication and plagiarism.

This offense is the second we know of for the corresponding author, Uttam Chand Banerjee, in the same journal, Applied Microbiology and Biotechnology. Last year, Banerjee—who works at National Institute of Pharmaceutical Education and Research (NIPER) in Mohali, Punjab, India—had a 14-year-old review retracted in Applied Microbiology and Biotechnology after an investigation revealed the authors had plagiarized from numerous sources and failed to reference them. At the time, Banerjee told us that he and his co-authors took a few lines from other reviews and that omitting the references was “simply unintentional.” According to The Indian Express, Banerjee also faced plagiarism allegations in 2005, and was denied a prestigious fellowship in 2011 as a result. Continue reading Author who previously claimed plagiarism was a mistake earns new erratum

“We would now catch” this conflict of interest: Hindawi journal retracts two papers

A computer science journal has retracted two papers, after discovering “a conflict of interest between the handling editor and one of the authors.”

Matt Hodgkinson, head of research integrity at Hindawi Limited, which publishes the journal Scientific World Journal, told us that the conflict of interest stemmed from the fact that Zheng Xu, an author on both papers, and Xiangfeng Luo, the handling editor on the papers, were “frequent collaborators.”

Xu—who is based at The Third Research Institute of Ministry of Public Security in Shanghai—and Luo—a professor in the School of Computer Engineering and Science at Shanghai University—have co-authored dozens of papers together, including several that were cited in the now-retracted articles. Luo also told us that Xu was his former PhD student.

When Hindawi approached Xu about the conflict of interest, Xu told us he “fully agreed” to retract the articles but claimed there was another reason for the retraction involving a special issue in the journal. More on that in a moment. Continue reading “We would now catch” this conflict of interest: Hindawi journal retracts two papers

UCSF, VA investigations find “clear evidence” of misconduct in cancer papers

Earlier this year, the University of California, San Francisco and the San Francisco Veterans Administration Medical Center teamed up to write a letter.

Addressed to the editorial office at the American Association of Cancer Research (AACR), the letter, parts of which have been published in a retraction notice, contained information concerning two papers on genetic risk factors for a type of kidney cancer and a type of uterine cancer, respectively, published in different AACR journals over a decade ago by researchers affiliated with the institutions.

The papers had been at the center of research misconduct investigations at both UCSF and the VA and the investigations came to the conclusion that both papers contained:

fabrication or falsification of data that constitutes Research Misconduct.

Though one of the papers has been retracted, it’s unclear what will happen to the other. [Note: See update at the bottom of the post.] Continue reading UCSF, VA investigations find “clear evidence” of misconduct in cancer papers

Did the author of a now-retracted article bribe a critic to silence him?

Authors react in a variety of ways to criticism of their work. Some stonewall, some grit their teeth but make corrections, and others thank their critics. But what about bribery? Continue reading Did the author of a now-retracted article bribe a critic to silence him?

Predatory journals: Not just a problem in developing world countries, says new Nature paper

David Moher

“Common wisdom,” according to the authors of a new piece in Nature, “assumes that the hazard of predatory publishing is restricted mainly to the developing world.” But the authors of the new paper, led by David Moher of the Ottawa Hospital Research Institute, found that more than half — 57% — of the 2,000 articles published in journals they determined were predatory were from high-income countries. In fact, the U.S. was second only to India in number of articles published in such journals. We asked Moher, who founded Ottawa Hospital’s Centre for Journalology in 2015, a few questions about the new work.

Retraction Watch (RW): Your paper comes out on the heels of a Bloomberg story showing that Big Pharma researchers are also publishing in predatory journals. Does all of this suggest that our understanding of who publishes in predatory journals is incomplete, or even wrong? Continue reading Predatory journals: Not just a problem in developing world countries, says new Nature paper

Data fabrication by ex-Harvard researcher takes down paper on Huntington’s disease

A researcher at Harvard Medical School and Massachusetts General Hospital is retracting a paper due to “inappropriate manipulation and fabrication of data” by the first author.

According to the retraction notice, published Aug. 22, corresponding author Marian DiFiglia is retracting the paper because the alleged misconduct by the first author, Antonio Valencia:

led to an incorrect conclusion in the paper that NADPH activity is elevated in Huntington’s disease (HD). Some original data were missing and efforts to replicate findings using the reported method or an alternative approach were unsuccessful. An institutional faculty panel supports the decision and the reasons for the retraction.

The notice added that the alleged data manipulation and fabrication affected bar graphs in two of the paper’s figures.

Terri Ogan, a spokesperson for Mass General, told Retraction Watch that Valencia no longer works at the institution, but declined to say whether there has been an investigation into the alleged misconduct: Continue reading Data fabrication by ex-Harvard researcher takes down paper on Huntington’s disease

Authors retract Science paper after investigation reveals manipulated images

Researchers at a prominent Japanese university have retracted a 2015 paper in Science, after an investigation uncovered image falsification and fabrication.

Last September, the University of Tokyo began an investigation of seven papers from the lab of cell biologist Yoshinori Watanabe after receiving anonymous allegations. In May 2017, the university determined that five papers contained falsified or fabricated images, and announced the results of its investigation on August 1. Two of the papers were published in Science, two in Nature and one in EMBO Reports.

On July 1 2017, EMBO Reports issued an erratum to the 2011 paper flagged in the investigation, correcting issues in several figures. Here’s the retraction notice for “The inner centromere–shugoshin network prevents chromosomal instability,” the 2015 paper in Science and the first of the papers to be retracted: Continue reading Authors retract Science paper after investigation reveals manipulated images

Amid legal battle, psych journal issuing caution about torture paper

A psychology journal plans to issue an editor’s note about a controversial paper exploring what the author called “the biggest scandal to hit” the American Psychological Association (APA) in years.

The note cautions readers that the subject of the paper, published in the SAGE journal Teaching of Psychology, is part of a pending lawsuit, and that “teachers considering using the article in their classrooms” should watch for developments in the case.   Continue reading Amid legal battle, psych journal issuing caution about torture paper